Kite Pharma just got FDA approval to kick off operations at a new manufacturing campus.
The cancer-focused, CAR-T cell therapy player made the announcement Monday, saying that the federal regulatory agency gave the green light to Kite’s 100,000 square-foot, retroviral vector manufacturing facility in Oceanside, CA.
Kite’s global head of…
